Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

British Journal of Cancer 117, 913 (26 September 2017). doi:10.1038/bjc.2017.274

Authors: Ashley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, Michael D Wiese, Howard Gurney, Ross A McKinnon, Chris S Karapetis & Michael J Sorich

http://ift.tt/2xgWp6u